Action A005500 SAMJIN PHARMACEUTICALS CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Samjin Pharmaceuticals Co., Ltd.

Actions

A005500

KR7005500004

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 01/07/2024 		Varia. 5j. Varia. 1 janv.
20 000 KRW +0,50 % Graphique intraday de Samjin Pharmaceuticals Co., Ltd. +0,20 % -7,41 %
03/06 Samjin Pharmaceuticals Co, Ltd. (KOSE:A005500) annonce un rachat d'actions pour une valeur de 5 000 millions KRW. CI
03/06 Samjin Pharmaceuticals Co. autorise un plan de rachat. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
Neurophet, Inc. announced that it has received KRW 1 billion in funding from Samjin Pharmaceuticals Co., Ltd.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on June 16, 2023 has expired with 227,116 shares, representing 1.74% for KRW 4,996.59 million.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on March 24, 2023, has expired with 228,833 shares, representing 1.73% for KRW 4,995.92 million.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on December 2, 2022, has expired with 183,020 shares, representing 1.36% for KRW 4,993.50 million.
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A005500
  4. Actualités Samjin Pharmaceuticals Co., Ltd.
  5. Autres langues